Try Calculator
← Back to Compound Library NOOTROPICS

Semax

Semax is a synthetic peptide derived from a fragment of adrenocorticotropic hormone (ACTH). Developed at the Russian Academy of Sciences in the 1980s, it has been used as a prescription medication in Russia for decades to treat stroke, traumatic brain injury, cognitive decline, and optic nerve disorders. Unlike many nootropics that work through stimulation, Semax enhances cognition by increasing brain-derived neurotrophic factor (BDNF) and supporting neuroplasticity. The name “Semax” comes from “seven amino acids” in Russian (СЕМь АминоКислот). It is a heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. This structure is based on ACTH(4–10), the portion of the hormone associated with cognitive effects, modified for improved stability and brain penetration. What makes Semax particularly interesting is its dual role: it functions as both a nootropic (cognitive enhancer) and a neuroprotectant. In healthy individuals, it sharpens focus, improves memory, and enhances mental clarity. In people recovering from stroke or brain injury, it accelerates healing and preserves brain function. This combination of acute performance benefits and long-term brain protection sets it apart from stimulant-based cognitive enhancers. Semax is administered intranasally in Russian clinical practice, allowing direct delivery to the brain. In the research community, subcutaneous injection is also used. It remains a research compound without FDA approval in the United States. Semax was first described in scientific literature in 1991 and has since been included on Russia’s List of Vital and Essential Drugs.

How It Works

Brain-Derived Neurotrophic Factor (BDNF) To understand why Semax works, it is essential to understand BDNF (brain-derived neurotrophic factor). BDNF is one of the most important proteins for brain health. It promotes the survival of existing neurons, encourages the growth of new neurons, and strengthens synaptic connections. Higher BDNF levels correlate with better learning, improved memory consolidation, and enhanced cognitive flexibility. Semax increases BDNF expression in the hippocampus and cortex. Research shows that a single dose can increase BDNF protein levels by approximately 1.4-fold and BDNF mRNA expression by up to 3-fold. It also increases the phosphorylation of the TrkB receptor by 1.6-fold, which is how BDNF signals its effects inside neurons. Additional studies have demonstrated increases in both BDNF and nerve growth factor (NGF) in the frontal cortex and hippocampus up to eight hours after administration.

Neurotransmitter Modulation

Beyond BDNF, Semax modulates multiple neurotransmitter systems. Research demonstrates that it increases serotonin metabolites by approximately 25% in the striatum, supporting mood stability and cognitive resilience. It also modulates dopamine release, particularly when combined with stimulants. In rodent studies, Semax potentiated the stimulatory effects of d- amphetamine on dopamine release, suggesting synergy with stimulant pathways. Additionally, Semax may increase the metabolism of acetylcholine and the circulation of monoamines in the brain. These monoamines have distinct cognitive actions: dopamine drives the association of cognitive tasks with a sense of reward, while serotonin may help individuals look past the effort costs that could discourage initiating a cognitive task.

Gene Expression and Immune Modulation

In stroke studies, genome-wide analysis showed that Semax affects 96 different genes at three hours post-dose, with over half related to immune response and vascular function. This broad gene-expression profile helps explain its neuroprotective effects during brain injury. Research suggests that the immune response is the process most markedly affected by the peptide, owing to its ability to enhance antigen presentation signaling, influence immunoglobulin synthesis, and stimulate interferon-signaling pathways.

Melanocortin Receptor Interaction

There is evidence that Semax may interact with melanocortin receptors. Specifically, Semax has been reported to competitively antagonize the action of alpha-melanocyte-stimulating hormone at the MC4 and MC5 receptors in both in vitro and in vivo experimental conditions, indicating that it may act as an antagonist or partial agonist of these receptors.

Additional Mechanisms

Semax also provides neuroprotection under conditions of oxidative stress and hypoxia, affects intracellular calcium dynamics, and inhibits enzymes involved in the degradation of enkephalins and other endogenous regulatory peptides. The practical result is enhanced focus, improved memory, better stress resilience, and protection against neurological damage. Unlike stimulants, which deplete neurotransmitters and lead to crashes, Semax builds the brain’s capacity through neurotrophic support.

Benefits

Cognitive Enhancement

The primary benefit for healthy users is improved mental performance. Research shows enhanced learning, better memory formation, and sharper attention. Users commonly report heightened alertness, improved verbal fluency, and better working memory. These effects come from BDNF upregulation and neurotransmitter modulation rather than stimulation. Human research has demonstrated improvements in attention and short-term memory parameters, and EEG studies have shown changes consistent with enhanced cognitive processing.

Neuroprotection

Semax protects neurons from damage caused by oxidative stress, hypoxia, and inflammation. In stroke models, it limits cell death and preserves brain function. Histological studies have shown that Semax activates the capillary network, increases proliferation of neuroglia and blood vessel endothelium, and promotes progenitor cell activity in the subventricular zone. This makes it valuable both for recovery from neurological injury and for long-term brain health maintenance.

Stroke Recovery

The strongest clinical evidence for Semax comes from stroke rehabilitation. Russian studies show that Semax treatment increases BDNF plasma levels, accelerates functional recovery, and improves motor performance in stroke patients. A clinical study of 110 stroke patients demonstrated that Semax administration increased BDNF plasma levels regardless of rehabilitation timing, and high BDNF levels correlated with better functional independence scores and improved motor performance. The effects are enhanced when combined with early rehabilitation.

Mood and Stress Resilience

Through its effects on serotonin and dopamine, Semax provides mood-stabilizing benefits. Users report improved emotional stability and better resilience under stress. A 2024 study of ACTH analogs in rodents showed that coadministration of Semax with another analog successfully reduced the severity of depressive symptoms and increased BDNF levels in the brain. An earlier study from 2010 found that Semax normalized behavior in rats induced with anxiety and depression. This is distinct from anxiolysis (Selank is better for direct anxiety relief); Semax is more about maintaining cognitive performance when stressed.

Optic Nerve Support

In Russian clinical practice, Semax is used for optic nerve disorders. Studies in patients with glaucomatous optic neuropathy showed visual field expansion averaging 57.5 degrees in 80% of treated eyes after 30 days of treatment. Patients also reported improved color perception and smaller blind spots. The mechanism involves BDNF-mediated neuroprotection of the optic nerve.

Immunomodulation

Emerging research highlights Semax’s effects on the immune system. It enhances antigen presentation signaling pathways, influences immunoglobulin synthesis, and stimulates interferon-signaling pathways. These properties suggest potential utility in supporting immune function, though this application remains an active area of investigation.

What the Science Shows

Semax has decades of clinical use in Russia and a substantial body of research. While many studies originate from Russian journals, the findings are consistent and compelling across multiple research groups and models.

Dolotov et al. (2006), Brain Research

This foundational study demonstrated that a single intranasal dose of Semax (50 mcg/kg) increased BDNF protein levels by 1.4-fold and BDNF mRNA by 3-fold in the rat hippocampus. TrkB receptor phosphorylation increased 1.6-fold. Semax-treated animals showed a distinct increase in conditioned avoidance reactions, supporting the cognitive enhancement mechanism. The researchers concluded that Semax affects cognitive brain functions by modulating the expression and activation of the hippocampal BDNF/TrkB system.

Gusev et al. (2018), Zhurnal Nevrologii i Psikhiatrii A clinical study of 110 stroke patients examined the effects of Semax on BDNF levels and functional recovery. The standard protocol consisted of 6,000 mcg/day for 10 days, repeated after a 20-day interval. Results showed that Semax administration increased BDNF plasma levels regardless of rehabilitation timing. High BDNF levels correlated with better Barthel scores (functional independence) and improved motor performance. Treated patients with high BDNF levels showed improved timing of rehabilitation.

Medvedeva et al. (2014), BMC Genomics

This genome-wide analysis examined Semax effects in a rat brain focal ischemia (stroke) model. The study found that Semax affected 96 genes at three hours post-administration, with over half related to immune response and vascular function. This helps explain the neuroprotective mechanism beyond simple BDNF upregulation, revealing a broad transcriptomic response that encompasses immune modulation, vascular function, and cellular repair.

Eremin et al. (2005), Neurochemical Research

This study showed that Semax activates both dopaminergic and serotonergic brain systems in rodents. Serotonin metabolites increased approximately 25% in the striatum. When combined with amphetamine, Semax potentiated dopamine release, suggesting synergy with stimulant pathways. These findings help explain Semax’s mood-stabilizing and cognitive-enhancing effects through neurotransmitter modulation.

Shadrina et al. (2010) This study demonstrated that Semax increased both BDNF and NGF (nerve growth factor) expression in the frontal cortex and hippocampus eight hours after administration. The multidirectional activation of neurotrophin gene expression across different brain regions helps explain the broad cognitive and neuroprotective benefits of the peptide.

Optic Nerve Studies

Clinical studies in patients with glaucomatous optic neuropathy showed visual field expansion averaging 57.5 degrees in 80% of treated eyes after 30 days of Semax treatment. Patients also reported improved color perception and reduction of blind spots. These results support BDNF- mediated neuroprotection as the mechanism for optic nerve recovery.

Manchenko et al. (2012), Neuroscience and Behavioral Physiology In healthy rats, intranasal and intraperitoneal Semax improved cognition (passive avoidance test) within 15 minutes after treatment. The study found that intranasal administration yielded a more pronounced improvement in learning compared to intraperitoneal injection, supporting the intranasal route as the preferred method for cognitive enhancement.

Dosing Protocol

Semax is primarily administered intranasally, though subcutaneous injection is also effective. In Russia, it is available in 0.1% and 1% solutions, with the higher concentration reserved for clinical conditions.

Understanding the Dosing Context

Clinical stroke protocols use much higher doses (6,000 mcg/day) than typical nootropic use (300 to 600 mcg/day). This reflects the difference between treating acute neurological damage and enhancing baseline cognition. For most people seeking cognitive enhancement, lower doses in cycles are appropriate.

Cognitive Enhancement Protocol

For general nootropic use:

overstimulation of BDNF pathways

Advanced Cognitive Protocol

For periods of high cognitive demand:

learning periods

Neuroprotection and Recovery

For recovery from neurological stress or injury (consult medical supervision):

Stacking with Selank

Semax and Selank complement each other well. Semax provides the stimulating, focus- enhancing effects while Selank provides calming, anxiolytic effects. Together they produce calm focus.

synergistically

Why Cycling Matters

Continuous BDNF stimulation can lead to receptor downregulation and diminished effects. Cycling allows the neurotrophin system to reset. Most Russian protocols use 10- to 14-day cycles with breaks of at least one week. Some users follow monthly cycles, while others use Semax only during demanding periods.

Draw Volumes by Vial Size

Semax is commonly available in 10 mg vials. 10 mg Vial (2 mL reconstitution = 5 mg/mL)

Dose Volume Units on Syringe 200 mcg 0.04 mL 4 units 300 mcg 0.06 mL 6 units 400 mcg 0.08 mL 8 units 600 mcg 0.12 mL 12 units

Vial duration at 300 mcg daily: approximately 33 days. Vial duration at 600 mcg daily: approximately 16 days. 10 mg Vial (3 mL reconstitution = 3.33 mg/mL)

Dose Volume Units on Syringe 200 mcg 0.06 mL 6 units

300 mcg 0.09 mL 9 units 400 mcg 0.12 mL 12 units 600 mcg 0.18 mL 18 units

Vial duration at 300 mcg daily: approximately 33 days. Vial duration at 600 mcg daily: approximately 16 days. The 3 mL reconstitution provides slightly easier measurements for precise dosing.

Reconstitution Instructions

1. Remove the flip-off cap from the vial and wipe the rubber stopper with an alcohol swab. 2. Draw the chosen volume of bacteriostatic water into a sterile syringe (2 mL or 3 mL). 3. Insert the needle through the rubber stopper at an angle. 4. Inject the water slowly down the inside wall of the vial to avoid foaming. 5. Gently swirl or roll the vial until the powder is fully dissolved. Do not shake vigorously. 6. The solution should be clear and colorless. 7. Label the vial with the reconstitution date and concentration. 8. Store in the refrigerator at 36 to 46 degrees Fahrenheit (2 to 8 degrees Celsius). 9. Use within 30 days for optimal potency.

Side Effects and Safety Profile

Semax has an excellent safety profile based on decades of clinical use in Russia. Side effects are generally mild and well-tolerated. Clinical data indicates a low incidence of adverse effects across multiple studies.

Common Effects

Less Common Effects

What Semax Does Not Cause

Contraindications and Precautions

Avoid If

Use with Caution If

Not a Replacement For

Comparison to Similar Compounds

Semax occupies a unique middle ground among nootropic and neuroprotective compounds. It is more stimulating than Selank but gentler than pharmaceutical stimulants. Its BDNF mechanism provides sustainable cognitive enhancement rather than borrowed energy that leads to crashes.

Compound Primary Effect Mechanism Stimulating Anxiolytic Semax Nootropic / BDNF / Moderate Mild Focus Dopamine /

Serotonin

Selank Anxiolytic / GABA None Strong Nootropic Modulation Noopept Nootropic Glutamate / Mild Mild

BDNF

Cerebrolysin Neuroprotection Multiple None None

Neurotrophins

Modafinil Wakefulness Dopamine / Strong None

Histamine

For most people seeking nootropic effects, Semax and Selank together provide the best balance of focus and calm. Semax provides the cognitive sharpening, while Selank provides the calm baseline. When combined with Cerebrolysin, the stack creates a powerful neurotrophic environment: Semax signals the brain to produce more growth factors, Cerebrolysin provides peptide fragments that mimic natural growth factors, and the combination promotes robust synaptic growth and repair.

Success Tips

Start with Lower Doses

Begin with 200 to 300 mcg daily to assess your response. Semax affects multiple neurotransmitter systems, and individual responses vary. You can increase to 400 to 600 mcg once you know how you respond.

Morning and Early Afternoon Dosing

Take Semax in the morning or split between morning and early afternoon. Avoid late-day dosing, as it may interfere with sleep in some individuals. The cognitive enhancement effects align well with work or study periods.

Use Cycles, Not Continuous Dosing

Stick to 10- to 14-day cycles followed by at least a week off. This maintains sensitivity and prevents the neurotrophin system from downregulating. Some people use Semax only during demanding periods rather than routinely.

Consider the Selank Stack

If you need both focus enhancement and stress management, combine Semax with Selank. Semax provides the cognitive sharpening while Selank provides the calm baseline. This is a well-established combination in the nootropic community.

Support Your Brain’s Needs

Semax increases your brain’s capacity for plasticity and learning, but you still need to use that capacity. Combine it with learning activities, challenging work, or skill development to maximize benefits. Sleep is also critical for consolidating the neuroplastic changes Semax supports.

Track Cognitive Metrics

Consider tracking working memory, reaction time, or other cognitive metrics during your cycle. The effects of Semax can be subtle, and tracking helps you identify whether it is working for you.

Storage and Handling

Before Reconstitution

Fahrenheit)

Fahrenheit) for shorter periods

After Reconstitution

Legal Status

Russia and CIS Countries: Approved prescription medication for stroke, cognitive decline, and optic nerve disorders. Listed on Russia’s List of Vital and Essential Drugs, approved by the Russian Federation government on December 7, 2011. United States: Not FDA approved. Available as a research compound. Not scheduled as a controlled substance. Europe: Not approved. Available through research chemical suppliers. WADA Status: Not currently on the prohibited list, but athletes should verify current regulations before use.

Frequently Asked Questions

How quickly does Semax work? Many users notice effects within the first few doses. The cognitive enhancement builds over the first week of a cycle. Unlike Selank, which can take several days to reach full effect, Semax tends to work more quickly. Studies have shown improved cognition within 15 minutes of administration in animal models. Is Semax a stimulant? Not in the traditional sense. It does not work like caffeine or amphetamines. It enhances cognition through BDNF upregulation and neurotransmitter modulation. Users describe the effect as “clean” focus rather than stimulation.

Can I use Semax daily?

Not continuously. Cycle it for 10 to 14 days on, then take at least a week off. Continuous use may lead to diminished effects as BDNF receptors downregulate. Semax or Selank: which should I use? It depends on your goals. Semax is better for focus, learning, and cognitive performance. Selank is better for anxiety reduction and calm. Many people use both together for balanced effects. Can I take Semax with coffee or other stimulants? Yes, and the combination often works well. Semax can enhance and extend the focus benefits of caffeine without amplifying the jitteriness. Start with lower doses of both when combining. Does Semax build tolerance? Yes, which is why cycling is important. Continuous use can lead to reduced effects. Taking regular breaks maintains sensitivity. Is intranasal or subcutaneous administration better? Research suggests intranasal administration may yield a more pronounced improvement in cognitive effects, which is why it is the preferred route in Russian clinical practice. However, subcutaneous injection is also effective and may provide additional benefits such as analgesic effects.

References

1. Dolotov OV, Karpenko EA, Inozemtseva LS, et al. Semax, an analog of ACTH(4–10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Research. 2006;1117(1):54– 60.

2. Gusev EI, Martynov MYu, Kostenko EV, et al. The efficacy of semax in the treatment of patients at different stages of ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(1):61–68. 3. Medvedeva EV, Dmitrieva VG, Povarova OV, et al. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014;15:228.

4. Eremin KO, Kudrin VS, Saransaari P, et al. Semax, an ACTH(4–10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents. Neurochemical Research. 2005;30(12):1493–1500.

5. Koroleva SV, Myasoedov NF. Semax as a universal drug for therapy and research. Biology Bulletin. 2018;45(6):589–600.

6. Ashmarin IP, Nezavibatko VN, Myasoedov NF, et al. A nootropic adrenocorticotropin analog 4–10- semax (15 years experience in its design and study). Zh Vyssh Nerv Deiat Im I P Pavlova. 1997;47(2):420–430.

7. Shadrina MI, Dolotov OV, Grivennikov IA, et al. Comparison of the temporal dynamics of NGF and BDNF gene expression in rat hippocampus, frontal cortex, and retina under Semax action. Doklady Biological Sciences. 2010;430:17–20.

8. Manchenko DM, Glazova NYu, Levitskaya NG, et al. Nootropic and analgesic effects of Semax following different routes of administration. Neuroscience and Behavioral Physiology. 2012;42(3):264– 270.

9. Kolomin TA, Shadrina MI, Slominsky PA, et al. A new generation of drugs: synthetic peptides based on natural regulatory peptides. Neuroscience and Behavioral Physiology. 2013;43(9):1067–1075.

Property Support

Our Property Support services are designed to help homeowners, property managers, and businesses maintain safe, clean, and well-functioning properties year-round.

Get In Touch